Use of Transgenic Mouse Models to Understand the Oral Disposition and Drug-Drug Interaction Potential of Cobimetinib, a MEK Inhibitor
Drug Metabolism and Disposition - United States
doi 10.1124/dmd.115.063743
Full Text
Open PDFAbstract
Available in full text
Date
March 26, 2015
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)